SANTORO, MASSIMO

SANTORO, MASSIMO  

DIPARTIMENTO DI MEDICINA MOLECOLARE E BIOTECNOLOGIE MEDICHE  

Mostra records
Risultati 1 - 20 di 338 (tempo di esecuzione: 0.038 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2). 1.1 Articolo in rivista 2003 Carlomagno, F; Vitagliano, D; Guida, T; Basolo, F; Castellone, Md; Melillo, ROSA MARINA; Fusco, Alfredo; Santoro, Massimo
Glial cell line-derived neurotrophic factor induces proliferative inhibition of NT2/D1 cells through RET-mediated up-regulation of the cyclin-dependent kinase inhibitor p27(kip1). 1.1 Articolo in rivista 2002 Baldassarre, G; Bruni, P; Boccia, A; Salvatore, G; Melillo, ROSA MARINA; Motti, Ml; Napolitano, M; Belletti, B; Fusco, Alfredo; Santoro, Massimo; Viglietto, G.
Human papilloma virus 16E7 oncogene does not cooperate with ret/ptc 3 oncogene in the neoplastic transformation of thyroid cells in transgenic mice 1.1 Articolo in rivista 2000 Portella, Giuseppe; Borselli, C.; Santoro, Massimo; Gerbasio, D.; D'Armiento, M. R.; Dumont, E. J.; Ledent, C.; Rothstein, J. L.; Vecchio, Giancarlo; Fusco, Alfredo
The docking protein FRS2 links RET and its oncogenic forms with the RAS/MAPK cascade. 1.1 Articolo in rivista 2001 Melillo, ROSA MARINA; Santoro, Massimo; S. H., Ong; M., Billaud; Fusco, Alfredo; J., Schlessinger; I., Lax
Ret-mediated mitogenesis requires Src kinase activity. 1.1 Articolo in rivista 1999 Melillo, ROSA MARINA; Barone, Mv; Lupoli, G; Cirafici, Am; Carlomagno, F; Visconti, R; Matoskova, B; DI FIORE, Pp; Vecchio, G; Fusco, Alfredo; Santoro, Massimo
Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes. 1.1 Articolo in rivista 2003 Castellone, Md; Cirafici, Am; DE VITA, G; DE FALCO, V; Malorni, L; Tallini, G; Fagin, Ja; Fusco, Alfredo; Melillo, ROSA MARINA; Santoro, Massimo
Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinase 1.1 Articolo in rivista 2002 Salvatore, Giuliana; Nagata, S.; Billaud, M.; Santoro, Massimo; Vecchio, Giancarlo; Pastan, I.
Genetic Alterations in differentiated thyroid cancer:what can be expected for gene expression profiling of thyroid carcinomas 1.1 Articolo in rivista 2003 Santoro, Massimo; Melillo, ROSA MARINA; Carlomagno, Francesca; Castellone, MARIA DOMENICA; Vitagliano, Donata; Guida, Teresa; Vecchio, Giancarlo; Fusco, Alfredo
Molecular mechanisms of RET activation in human cancer 2.1 Contributo in volume (Capitolo o Saggio) 2002 Santoro, Massimo; Melillo, ROSA MARINA; Carlomagno, F; Fusco, Alfredo; Vecchio, Giancarlo
Conditional expression of RET/PTC induces a weak oncogenic drive in thyroid PCCL3 cells and inhibits thyrotropin action at multiple levels. 1.1 Articolo in rivista 2003 Wang, J; Knauf, Ja; Basu, S; Puxeddu, E; Kuroda, H; Santoro, Massimo; Fusco, Alfredo; Fagin, Ja
The neuron-specific Rai (ShcC) adaptor protein inhibits apoptosis by coupling Ret to the phosphatidylinositol 3-kinase/Akt signaling pathway. 1.1 Articolo in rivista 2002 Pelicci, G; Troglio, F; Bodini, A; Melillo, ROSA MARINA; Pettirossi, V; Coda, L; DE GIUSEPPE, A; Santoro, Massimo; Pelicci, Pg
Tyrosine 1062 of RET-MEN2A mediates activation of Akt(PKB) and MAPK pathways leading to PC12 cell survival. 1.1 Articolo in rivista 2000 DE VITA, G; Melillo, ROSA MARINA; Carlomagno, C; Visconti, R; Castellone, Md; Bellacosa, A; Billaud, M; Fusco, Alfredo; Tsichlis, Pn; Santoro, Massimo
The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes 1.1 Articolo in rivista 2002 Carlomagno, Francesca; Vitagliano, Donata; Guida, Teresa; Napolitano, M.; Vecchio, Giancarlo; Fusco, Alfredo; Gazit, A.; Levitzki, A.; Santoro, Massimo
The Insulin Receptor Substrate (IRS)-1 recruits Phosphatidylinositol 3-Kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret. 1.1 Articolo in rivista 2001 Melillo, ROSA MARINA; Carlomagno, Francesca; DE VITA, Gabriella; Formisano, Pietro; Vecchio, Giancarlo; Fusco, Alfredo; Billaud, M.; Santoro, Massimo
The RET receptor: function in development and dysfunction in congenital malformation. 1.1 Articolo in rivista 2001 Manie, S; Santoro, Massimo; Fusco, Alfredo; Billaud, M.
RET activation and clinicopathologic features in poorly differentiated thyroid tumors. 1.1 Articolo in rivista 2002 Santoro, Massimo; Papotti, M; Chiappetta, G; GARCIA ROSTAN, G; Volante, M; Johnson, C; Camp, Rl; Pentimalli, F; Monaco, C; Herrero, A; Carcangiu, Ml; Fusco, Alfredo
MicroRNA deregulation in human thyroid papillary carcinomas. 1.1 Articolo in rivista 2006 Pallante, Pierlorenzo; Visone, R; Ferracin, M; Ferraro, A; Berlingieri, Mt; Troncone, Giancarlo; Chiappetta, G; Liu, Cg; Santoro, Massimo; Negrini, M; Croce, Cm; Fusco, Alfredo
Molecular mechanisms of RET activation in human neoplasia 2.1 Contributo in volume (Capitolo o Saggio) 2002 Santoro, Massimo; Carlomagno, F; Melillo, ROSA MARINA; Vecchio, Giancarlo; Fusco, Alfredo
membro editorial board 8.06 Partecip. Editorial Board di riviste scientifiche 2007 Santoro, Massimo
Highly selective toxic and proapoptotic effects of two dimeric ribonucleases on thyroid cancer cells compared to the effects of doxorubicin 1.1 Articolo in rivista 2004 Spalletti Cernia, D.; Sorrentino, R.; Di Gaetano, S.; Piccoli, Renata; Santoro, Massimo; D'Alessio, Giuseppe; Laccetti, Paolo; Vecchio, Giancarlo